SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUARDIGLI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.407
AS - Asia 2.264
EU - Europa 1.045
SA - Sud America 417
AF - Africa 74
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.311
SG - Singapore 934
CN - Cina 501
BR - Brasile 339
VN - Vietnam 286
IT - Italia 218
HK - Hong Kong 188
DE - Germania 187
UA - Ucraina 146
GB - Regno Unito 106
TR - Turchia 81
FI - Finlandia 78
FR - Francia 74
JP - Giappone 66
IN - India 56
SE - Svezia 46
RU - Federazione Russa 45
CA - Canada 41
MX - Messico 38
BD - Bangladesh 32
AR - Argentina 31
NL - Olanda 28
ZA - Sudafrica 25
ID - Indonesia 23
PL - Polonia 23
IQ - Iraq 21
ES - Italia 20
CO - Colombia 15
LT - Lituania 15
UZ - Uzbekistan 11
KE - Kenya 10
MA - Marocco 10
PK - Pakistan 10
AT - Austria 9
BE - Belgio 9
EG - Egitto 9
MY - Malesia 8
PH - Filippine 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
DK - Danimarca 7
SA - Arabia Saudita 7
BO - Bolivia 6
EC - Ecuador 6
TN - Tunisia 6
IE - Irlanda 5
AL - Albania 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
PE - Perù 3
SV - El Salvador 3
BW - Botswana 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 7.212
Salva come PNG Salva come JPEG
Città #
Singapore 586
Ashburn 511
San Jose 259
Woodbridge 210
Santa Clara 198
Hong Kong 183
Chandler 174
Fairfield 167
Jacksonville 151
Beijing 139
Houston 130
Ho Chi Minh City 93
Ann Arbor 88
New York 78
Hanoi 76
Wilmington 76
Munich 75
Seattle 71
Los Angeles 69
Tokyo 64
Dallas 58
Nanjing 52
Cambridge 46
Princeton 44
Izmir 43
Lauterbourg 42
São Paulo 39
Helsinki 32
Shanghai 32
Milan 31
Boardman 28
Mexico City 27
San Diego 27
Bologna 25
Orem 25
Council Bluffs 24
Ferrara 24
London 21
Denver 20
Warsaw 20
Bremen 19
Buffalo 19
Brooklyn 18
Chicago 18
Atlanta 17
Stockholm 17
Da Nang 16
The Dalles 16
Turku 16
Jakarta 14
Johannesburg 14
Phoenix 14
Shenyang 14
Chennai 13
Hefei 13
Montreal 13
Toronto 12
Falls Church 11
Rome 11
Tashkent 11
Tianjin 10
Boston 9
Düsseldorf 9
Haiphong 9
Nairobi 9
Naples 9
New Delhi 9
Poplar 9
Rio de Janeiro 9
San Francisco 9
Brussels 8
Changsha 8
Dhaka 8
Jiaxing 8
Moscow 8
Nanchang 8
Amsterdam 7
Belo Horizonte 7
Dearborn 7
Hebei 7
Nuremberg 7
Thái Nguyên 7
Acireale 6
Baghdad 6
Cairo 6
Falkenstein 6
Goiânia 6
Kunming 6
Manchester 6
Ninh Bình 6
Odense 6
Redwood City 6
Sydney 6
Addison 5
Bogotá 5
City of London 5
Erbil 5
Fortaleza 5
Frankfurt am Main 5
Jinan 5
Totale 4.636
Salva come PNG Salva come JPEG
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 239
Reperfusion Damage - A Story of Success, Failure, and Hope 224
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 205
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 201
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 195
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 194
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 192
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 181
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 180
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 177
Bradykinin and coronary artery disease 176
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 174
A modern fairy tale 173
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 170
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 167
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 165
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 163
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 163
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 158
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 158
Angiotensin II overproduction: enemy of the vessel wall 158
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 153
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 150
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 150
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 149
Oxidative stress during myocardial ischaemia and heart failure 147
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 146
The heart rate story 146
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 145
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 141
Ferrara VI 140
Safety and efficacy of new-generation coronary bioresorbable scaffolds 137
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 130
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 130
FERRARA: CITTÀ DELLA PREVENZIONE 128
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 127
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 126
LEFT VENTRICULAR REMODELLING AT THE LIMITS 116
Multimodality imaging in acromegalic cardiomiopathy: a case report 113
Ferrara II 113
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 108
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 100
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 98
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 97
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 94
One-year outcome of elderly patients with endocarditis: a retrospective observational study 90
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 86
The future of cardiovascular prevention: between fiction and reality 73
null 61
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 51
Cardiovascular prevention: sometimes dreams can come true 42
Physical activity and cardiac rehabilitation after myocardial infarction: the risk of obtaining large benefits 7
Totale 7.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 503
Totale 33.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/20251.326 23 35 87 71 162 127 44 53 270 126 177 151
2025/20263.504 397 155 276 475 576 259 386 236 336 400 8 0
Totale 7.307